Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05601284
Other study ID # 12981
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 24, 2022
Est. completion date April 30, 2026

Study information

Verified date December 2023
Source Utah State University
Contact Mercedes Woolley, BA
Phone 3859551049
Email mercedes.woolley@usu.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators are proposing to test Acceptance and Commitment Therapy (ACT)+ traditional audiological behavioral intervention as an integrated, multi-disciplinary approach for the assessment and treatment of misophonia. Participants will be 60 adults with misophonia and will be randomly assigned to receive 12 sessions of ACT+behavioral intervention or receive 12 weeks of progressive relaxation training+psychoeducation (PRT; a commonly used active control condition) after undergoing a comprehensive psychological and audiological evaluation.


Description:

Acceptance and commitment therapy (ACT) is a promising psychotherapy for supporting traditional behavioral methods for treating misophonia, but has not been previously tested. ACT teaches skills to develop acceptance, mindfulness, and defusion from difficult internal experiences while increasing connections with personal values and encouraging meaningful behavioral changes. This study will help determine if ACT+behavioral intervention is a feasible and acceptable treatment for misophonia, help clarify active psychological mechanisms of misophonia, and determine whether or not this combination of services can effectively help individuals diagnosed with misophonia.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date April 30, 2026
Est. primary completion date October 30, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Individuals seeking treatment for misophonia. - Meet clinical cut-off for misphonia (minimum score of five on the Misophonia Questionnaire). - Stable on psychotropic medication for at least 30 days. - English speaking. Exclusion Criteria: - Presence of psychological and/or neurological impairments that would preclude someone from participating in the study or exceed misophonia as the primary presenting problem (e.g. active self-harm or need for treatment for psychosis).

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Acceptance and commitment therapy
ACT teaches skills to develop acceptance, mindfulness, and defusion from difficult internal experiences while increasing connections with personal values and encouraging meaningful behavioral changes. ACT for misophonia combines core ACT processes with a traditional audiological behavioral intervention for a integrated, multi-disciplinary approach for the assessment and treatment of misophonia. Treatment begins with a brief focus on the behavioral intervention, followed by the teaching of ACT skills to support the use of the behavioral methods. The intervention consists of 12 total individual sessions of ACT+behavioral management.
Progressive relaxation training
PRT for misophonia consists of basic psychoeducation for misophonia followed by PRT. PRT involves learning to tense and relax muscles. Early sessions focus on tensing and relaxing smaller muscle groups, while later sessions focus on larger muscle groups. Final sessions focus on relaxation as produced by recalling previous relaxation and a review of skills learned. PRT consists of 12 individual total sessions.

Locations

Country Name City State
United States Utah State University Logan Utah

Sponsors (1)

Lead Sponsor Collaborator
Utah State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Misophonia Questionnaire Self-report of misophonia symptoms. There are two subscales. The first subscale (misophonia symptoms) ranges from 0 to 76 and the second (misophonia severity) ranges from 1 to 15. For both subscales, higher scores indicate worse outcomes. 9-12 months
See also
  Status Clinical Trial Phase
Completed NCT04198597 - Exploring Two Treatments for Misophonia N/A
Completed NCT04348591 - Identifying the Optimal Neural Target for Misophonia Interventions N/A
Recruiting NCT06333925 - Using Neurostimulation to Accelerate Change in Misophonia: a Pilot Study N/A
Completed NCT05993286 - Treatment of Misophonia: Comparison of Exposure and Sound Therapy N/A
Enrolling by invitation NCT05928689 - Behavioral and Pharmacological Reconsolidation Interference in Misophonia Early Phase 1
Completed NCT04612374 - Exploring the Acceptability and Efficacy of a Transdiagnostic Treatment for Misophonia N/A
Recruiting NCT04365543 - Treatment for Youth (Ages 8 to 16 Years Old) With Misophonia (U-HEAR) N/A